US 12163148
Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9
granted A61KA61K48/00A61P
Quick answer
US patent 12163148 (Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9) held by The Regents of the University of California expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K48/00, A61P, A61P21/00